45 Biggest Movers From Yesterday

Gainers

• Camber Energy, Inc.. CEI shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking.
• Merus N.V. MRUS jumped 37.5% to close at $27.49 as the company presented early clinical data on MCLA-158 and preclinical data on zenocutuzumab at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics.
• New Fortress Energy Inc. NFE shares climbed 25.5% to close at $33.26 after the company issued gas supply and economic guidance.
• Nutriband Inc. NTRB gained 25.1% to close at $7.83. Nutriband's AVERSA Technology recently received Notice of Allowance from USPTO for application titled 'Abuse and Misuse Deterrent Transdermal Systems.'
• Aehr Test Systems AEHR jumped 22.4% to close at $16.66 in sympathy with the overall market on optimism Congress will near a deal that would prevent a government shutdown.
• PEDEVCO Corp. PED rose 21.5% to settle at $1.98 as a popular Twitter account Will Meade said is long stock.
• Burcon NutraScience Corporation BRCN gained 20.4% to close at $1.65.
• Alpha Teknova, Inc. TKNO rose 20.1% to settle at $26.13.
• Paltalk, Inc. PALT shares gained 19.3% to settle at $8.27 after dropping over 15% on Wednesday. Paltalk’s recent filing showed registration for $50 million mixed securities shelf offering.
• Altisource Portfolio Solutions S.A. ASPS climbed 18.3% to close at $11.75 as the company agreed to sell Pointillist subsidiary for $150 million.
• Amplify Energy Corp. AMPY rose 17.2% to settle at $3.40.
• Bicycle Therapeutics plc BCYC jumped 16.7% to close at $48.69. Bicycle Therapeutics reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-escalation portion of the BT8009 trial.
• Q&K International Group Limited QK rose 16.7% to settle at $0.77.
• Xiaobai Maimai Inc. HX gained 16.5% to close at $3.04.
• Theseus Pharmaceuticals, Inc. THRX rose 16.1% to settle at $18.58 as the company priced its IPO at $16 per share.
• Richardson Electronics, Ltd. RELL jumped 15.5% to close at $11.65 after reports first quarter fiscal 2022 net income of $2.6 million.
• Tata Motors Limited. TTM gained 15.3% to close at $25.75 after Morgan Stanley upgraded the company's stock from Equal-Weight to Overweight.
• Resources Connection, Inc. RGP climbed 15.2% to close at $19.25 following upbeat quarterly results.
• U.S. Silica Holdings, Inc. SLCA surged 14.6% to close at $9.72 after the company announced it is commencing a review of strategic alternatives for its Industrial & Specialty Products segment.
• Yatsen Holding Limited YSG rose 12.6% to settle at $4.10.
• Cyren Ltd. CYRN gained 12.1% to settle at $0.5460 after the company announced Nasdaq granted its request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement.
• Biotricity, Inc. BTCY gained 11.6% to close at $3.09. Biotricity announced the launch of Biocare Cardiac application for Samsung's Galaxy Watch4 series.
• NeuroMetrix, Inc. NURO gained 11.4% to close at $9.60. NeuroMetrix submitted a De Novo request to the FDA for Quell as a prescription treatment for fibromyalgia symptoms in adults. The Company received FDA Breakthrough Designation for this indication in July.
• Rocket Lab USA, Inc. RKLB rose 10.4% to close at $15.46 after the company disclosed that it has been selected to launch NASA's Advanced Composite Solar Sail System.
• AppLovin Corporation APP shares climbed 10.3% to close at $84.94. Twitter agreed to sell its MoPub mobile ad unit to AppLovin for $1.05 billion in cash.
• DatChat, Inc. DATS gained 9.2% to close at $8.04 after dropping 17% on Wednesday.
• Levi Strauss & Co. LEVI rose 8.5% to close at $26.29 as the company posted upbeat Q3 results and raised FY21 earnings forecast.

Check out these big penny stock gainers and losers

Losers

• Prelude Therapeutics Incorporated PRLD shares dipped 39.8% to settle at $17.34 on Thursday. Prelude Therapeutics announced presentation of data from multiple programs at AACR-NCI-EORTC Virtual International Conference.
• Osmotica Pharmaceuticals plc OSMT shares tumbled 37.6% to close at $1.91 on Thursday as the company priced its secondary public offering of 14 million shares and warrants to purchase up to 14 million shares at $2.5/piece.
• ORIC Pharmaceuticals, Inc. ORIC fell 35.4% to close at $12.28 after the company presented initial clinical data from Phase 1b trial of ORIC-101 in combination with enzalutamide and preclinical data on ORIC-114 at AACR-NCI-EORTC.
• Turning Point Therapeutics, Inc. TPTX fell 23.3% to close at $46.55. Turning Point Therapeutics presented updated preliminary clinical data for repotrectinib and elzovantinib at 2021 AACR-NCI-EORTC Conference and issued regulatory updates.
• Volcon, Inc. VLCN fell 19.9% to close at $8.70. Volcon shares jumped over 97% on Wednesday as the company priced its IPO at $5.50 per share.
• Eliem Therapeutics, Inc. ELYM dipped 14.4% to settle at $15.26.
• Forma Therapeutics Holdings, Inc. FMTX fell 13.1% to close at $20.45. Forma Therapeutics reported initial results from a Phase 1 trial of its novel CBP/p300 inhibitor, the oral small molecule FT-7051, in men with metastatic castration-resistant prostate cancer.
• Repare Therapeutics Inc. RPTX declined 12.2% to close at $21.90.
• Relay Therapeutics, Inc. RLAY fell 11.9% to close at $26.00. Relay Therapeutics, shared preclinical data at the virtual AACR-NCI-EORTC Molecular Targets Conference for RLY-2608, the first allosteric, pan-mutant and isoform-selective PI3Kα inhibitor.
• The Joint Corp. JYNT dropped 11.3% to settle at $85.53 after Bear Cave issued a short report.
• Cytosorbents Corporation CTSO shares fell 9.8% to close at $7.20.
• Priority Technology Holdings, Inc. PRTH declined 9.7% to close at $5.48.
• ATIF Holdings Limited ATIF dropped 9.6% to close at $4.22.
• F45 Training Holdings Inc. FXLV fell 8.9% to settle at $14.05.
• BP Prudhoe Bay Royalty Trust BPT fell 8.8% to close at $3.73.
• NRx Pharmaceuticals, Inc. NRXP shares fell 7.9% to close at $7.79 after dropping over 4% on Wednesday. NRx Pharmaceuticals recently issued an update on NIH Sponsored ACTIV-3b critical care study.
• Xeris Pharmaceuticals, Inc. XERS fell 6.8% to close at $2.20.
• Lamb Weston Holdings, Inc. LW dropped 6.6% to close at $58.20 after reporting Q1 results.